The cytosolic PRMT5-CDK4 complex impairs cell cycle kinase signaling
Sarah MasseriD, Tanja Lotteritsch, Anton Emil Ludwig, Bettina HalwachsiD, Elisabeth AnnereriD, Marion MußbacheriD, Ulrich StelzliD
Abstract
Both, protein arginine methyltransferases (PRMTs) and protein kinases are critical regulators of cellular processes and frequently dysregulated in malignancy. To systematically study the crosstalk of the two regulatory enzyme classes, we used parallel yeast two-hybrid matrix screening and defined 45 interactions connecting 4 PRMTs and 20 human kinases. The PRMT-kinase network revealed a strong association between PRMTs and cell cycle/mitogen-activated kinases. Notably, the PRMT5-CDK4 emerged as the most prominent functional cell cycle link through integrative data analyses of different high-throughput datasets. Mechanistic cell biological studies confirmed that the PRMT5-CDK4 complex localizes exclusively in the cytosol, where its formation was enhanced during a G1/S cell cycle block. This PRMT5 interaction modulated the CDK4-CCND3 and CDK4-CDKN2A interaction dynamics, irrespective of PRMT5s methyltransferase activity. Phospho-proteomic profiling demonstrated that PRMT5 overexpression functionally phenocopies the signaling effects of pharmacological CDK4 inhibition with Palbociclib. The findings establish a non-enzymatic regulatory role for PRMT5, proposing it functions as an inhibitory modulator of CDK4-driven oncogenic signaling.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PRMT5 activity sustains histone production to maintain genome integrity
Jacob S. Roth, Joseph D. DeAngelo, … David Shechter·bioRxiv·Jul 3, 2025
- The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing
Colin E Fowler, Natalie A. O’Hearn, … Jacqueline A. Lees·iSciencePeer-reviewed·Jun 20, 2025
- Increased activity of PRMT5-MEP50 complex improves survival of chromosomally unstable cancer cells by increasing tolerance to protein aggregation and proteotoxicity
Maria F. Suárez Peredo Rodríguez, Laura J. Jilderda, … Floris Foijer·bioRxiv·Sep 12, 2025
- Discovery of a first-in-class inhibitor of the PRMT5-substrate adaptor interaction
D. C. McKinney, B. J. McMillan, … A. Ianari·bioRxiv·Feb 3, 2021
- Distinct roles for CDK-Mediator in controlling Polycomb-dependent chromosomal interactions and priming genes for induction
Emilia Dimitrova, Angelika Feldmann, … Robert J. Klose·bioRxiv·Nov 4, 2021
- Cross-regulation between CDK and MAPK control cellular fate
E. Durandau, S. Pelet·bioRxiv·May 1, 2019